Table 1. Clinical characteristics and biopsy outcomes of the study population stratified by biopsy outcome.
| Variables | Total | Non-Cancer | Cancer |
|---|---|---|---|
| No.Patients | 1018 | 763 | 255 |
| Age, years | 66 (60, 72) | 65 (59, 70) | 68 (63, 74) |
| PSA, ng/ml | 9 (6, 12) | 8 (6, 11) | 10 (7, 14) |
| %fPSA | 13.4 (9.2, 19.4) | 14.9 (9.7, 20.9) | 10.9 (8.4, 15.7) |
| Prostate volume, cm3 | 40 (30, 55) | 45 (31, 60) | 35 (24, 43) |
| DRE Abnormal (%) | 9 | 8 | 16 |
| TRUS or MRI Abnormal (%) | 25 | 22 | 36 |
| Height, cm | 170 (166, 173) | 170 (166, 173) | 170 (165, 174) |
| Weight, kg | 68 (61, 75) | 68 (62, 75) | 68 (60, 75) |
| Recent BMI, kg/m2 | 24 (22, 25) | 24 (22, 25) | 24 (22, 25) |
| Waist circumference, cm | 86 (81, 91) | 85 (81, 90) | 86 (81, 91) |
| Hip circumference, cm | 95 (91, 99) | 95 (91, 99) | 95 (90, 100) |
| WHR | 0.903 (0.878, 0.929) | 0.900 (0.876, 0.927) | 0.907 (0.888, 0.934) |
| Smokers (%) | |||
| ever | 43 | 41 | 47 |
| never | 57 | 59 | 53 |
| Alcohol use (%) | |||
| ever | 39 | 39 | 39 |
| never | 61 | 61 | 61 |
| Hypertension (%) | 34 | 33 | 36 |
| Diabetes mellitus (%) | 10 | 10 | 10 |
| Biopsy outcome = cancer, n (%) | 255 (25) | 0 | 255 (100) |
| Gleason score, n (%) | |||
| 6 | 55 (5) | — | 55 (22) |
| 7 | 97 (10) | — | 97 (38) |
| 8 | 43 (4) | — | 43 (17) |
| 9 | 49 (5) | — | 49 (19) |
| 10 | 11 (1) | — | 11 (4) |
^Continuous variables are shown as the median value and interquartile range.